2013
DOI: 10.7883/yoken.66.306
|View full text |Cite
|
Sign up to set email alerts
|

HIV-1 Subtypes and Primary Antiretroviral Resistance Mutations in Antiretroviral Therapy Naive HIV-1 Infected Individuals in Turkey

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
9
1
1

Year Published

2015
2015
2017
2017

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 20 publications
0
9
1
1
Order By: Relevance
“…The most frequently detected non-B subtype was CRF02_AG, which is a circulating recombinant form in West Africa. The fact that nearly 50 % of the subtypes in this cohort of heterosexual patients were non-B subtypes and that the origin of infection was predominant in Turkey reflects a high prevalence of HIV-1 non-B infections in Turkey [21,22].…”
Section: Resultsmentioning
confidence: 82%
See 1 more Smart Citation
“…The most frequently detected non-B subtype was CRF02_AG, which is a circulating recombinant form in West Africa. The fact that nearly 50 % of the subtypes in this cohort of heterosexual patients were non-B subtypes and that the origin of infection was predominant in Turkey reflects a high prevalence of HIV-1 non-B infections in Turkey [21,22].…”
Section: Resultsmentioning
confidence: 82%
“…Anti-HIV drugs have become broadly available for the treatment of HIV-positive patients in Turkey, and the genetic diversity of HIV-1 has been analysed in recent studies showing that besides subtype B, the CRFs 02_AG, 01_AE and 03_AB are circulating [2,22,37].…”
mentioning
confidence: 99%
“…The lower prevalence of NRTI backbone treatment mutations and the higher prevalence of TAMs may be associated with an increase in HIV-1 infection in men who have sex with men (MSM) in the past 2 years (in 2012, 23% of patients were MSM, compared to 43% in this study). 12 Significant proportions of the patients with TDRMs have revertant TAMs, which transmit but do not reduce drug susceptibility. The largest proportion of TAMs included first by position of 215C/D/F/S/Y and second D67N, K219Q, or M41L mutations.…”
Section: Discussionmentioning
confidence: 99%
“…HIV-1 cDNA synthesis was done with the First Strand cDNA Synthesis Kit (Thermo Scientific Inc., Fermentas, Lithuania) including the M-MuLV reverse transcriptase enzyme. The PCR conditions were 95°C for 10 min, and then 45 cycles consisting of 95°C for 45 s, 55°C for 45 s, and 72°C for 45 s. 12 All PCR products were purified using the Highly Pure PCR Product Purification Kit (Roche Diagnostics GmbH, Mannheim, Germany) and directly sequenced with ABI PRISM 310 Genetic Analyzer equipment using the DYEnamic ET Terminator Cycle Sequencing Kit (Amersham Pharmacia Biotech Inc., Piscataway, NJ). The following thermal protocol …”
Section: Pcr Amplification and Sequence Analysismentioning
confidence: 99%
See 1 more Smart Citation